Skip to main content
34°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(NY:
RVTY
)
114.66
+2.63 (+2.35%)
Official Closing Price
Updated: 7:00 PM EST, Nov 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about RVTY
< Previous
1
2
Next >
Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK
November 20, 2024
From
Revvity
Via
Business Wire
Scale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells
November 19, 2024
From
Scale Biosciences
Via
Business Wire
Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference
November 19, 2024
From
Revvity
Via
Business Wire
Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent Transformation
November 18, 2024
From
Revvity
Via
Business Wire
Revvity Announces Financial Results for the Third Quarter of 2024
November 04, 2024
From
Revvity
Via
Business Wire
Revvity Board Declares Quarterly Dividend
October 24, 2024
From
Revvity
Via
Business Wire
Revvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical Laboratories
October 22, 2024
From
Revvity
Via
Business Wire
Revvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact Report
October 22, 2024
From
Revvity
Via
Business Wire
Revvity To Hold Earnings Call on Monday, November 4, 2024
October 07, 2024
From
Revvity
Via
Business Wire
Revvity's EUROIMMUN Launches Solution for Specific Typing of Alzheimer's Disease Associated APOE Gene
October 02, 2024
From
Revvity
Via
Business Wire
Revvity to Present at Upcoming Investor Conferences
August 21, 2024
From
Revvity
Via
Business Wire
Revvity Announces Financial Results for the Second Quarter of 2024
July 29, 2024
From
Revvity
Via
Business Wire
Revvity Board Declares Quarterly Dividend
July 25, 2024
From
Revvity
Via
Business Wire
Revvity To Hold Earnings Call on Monday, July 29, 2024
July 09, 2024
From
Revvity
Via
Business Wire
Revvity to Present at Goldman Sachs Global Healthcare Conference
May 28, 2024
From
Revvity
Via
Business Wire
Revvity Announces Financial Results for the First Quarter of 2024
April 29, 2024
From
Revvity
Via
Business Wire
Revvity Board Declares Quarterly Dividend
April 25, 2024
From
Revvity
Via
Business Wire
Revvity to Present at BofA Securities 2024 Health Care Conference
April 25, 2024
From
Revvity
Via
Business Wire
Revvity Unveils a New Era of Automated Tuberculosis Testing
April 24, 2024
From
Revvity
Via
Business Wire
Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners
April 15, 2024
From
Revvity
Via
Business Wire
Revvity To Hold Earnings Call on Monday, April 29, 2024
April 04, 2024
From
Revvity
Via
Business Wire
Preliminary Injunction Granted to Enforce Revvity’s Rights and Cloud Software Group’s Obligations Related to Spotfire Software
April 02, 2024
From
Revvity
Via
Business Wire
Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software Group
March 20, 2024
From
Revvity
Via
Business Wire
Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication
March 18, 2024
From
Revvity
Via
Business Wire
Revvity to Present at Upcoming Investor Conferences
February 21, 2024
From
Revvity
Via
Business Wire
Revvity Signals Software Unveils Signals Clinical Solution to Accelerate Critical Clinical Trial Insights and Data-Driven Decisions
February 12, 2024
From
Revvity
Via
Business Wire
Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2023
February 01, 2024
From
Revvity
Via
Business Wire
Revvity Elects Sophie Vandebroek and Michael Klobuchar to its Board of Directors
January 25, 2024
From
Revvity
Via
Business Wire
Revvity Board Declares Quarterly Dividend
January 25, 2024
From
Revvity
Via
Business Wire
Revvity to Hold Earnings Call on Thursday, February 1, 2024; Provides Update on Financial Performance
January 09, 2024
From
Revvity
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.